While P counteracts estrogen-promoted proliferation in healthy endometrium, this effect is lost or decreased on the endometrium of adenomyosis patients, due to lower immunoreactivity of PR-B secondary to promoter hypermethylation of PR-B, ultimately resulting in P resistance and this aids in fostering abnormal endometrial proliferation [65,66]. Here, RB1 is linked to adenomyosis.